Literature DB >> 9503605

Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity.

H Kataoka1, H Tahara, T Watanabe, M Sugawara, T Ide, M Goto, Y Furuichi, M Sugimoto.   

Abstract

The immunological characteristics and immortalization processes of three EBV-transformed human B-lymphoblastoid cell lines, N0003, N0005 and N6803, with strong telomerase and infinitively proliferating activities are described. The three cell lines were apparently immortalized: they developed a strong telomerase activity at the population doubling levels (PDLs) between 11 and 135, and continued proliferation over 250 PDLs. All the cell lines expressed CD22, CD19 and CD20 antigens. They were uniformly stained with IgM (N0005), IgG (N6803) or IgA (N0003) at early PDLs between 17 and 20, and they secreted the corresponding class of Ig into the medium; the N6803 and N0003 cell lines continued to secrete each class of Ig at decreased levels while the N0005 cell line expressed or secreted virtually no Ig after immortalization. Karyotype analysis of the immortalized cell lines showed that they were derived from a single cell because they shared a set of abnormal chromosomes within each cell population, and two of the cell lines attained clonal characteristics before they developed a strong telomerase activity. These results indicate that the three immortalized cell lines with a strong telomerase activity correspond to the intermediate stages of B-cell differentiation naturally committed to a specific Ig class, and suggest that they were derived from a B-lymphoblastoid cell committed to a specific class of Ig with poor telomerase activity, rather than from a strongly telomerase-positive B-lymphoblastoid cell either committed or multipotential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503605     DOI: 10.1046/j.1432-0436.1998.6240203.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  11 in total

1.  Incorrect us of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  M Sugimoto; Y Furuichi; T Ide; M Goto
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Novel isolation and biochemical characterization of immortalized fibroblasts for tissue engineering vocal fold lamina propria.

Authors:  Xia Chen; Susan L Thibeault
Journal:  Tissue Eng Part C Methods       Date:  2009-06       Impact factor: 3.056

Review 3.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

4.  Long-term Culture of EBV-induced Human Lymphoblastoid Cell Lines Reveals Chromosomal Instability.

Authors:  Marianne Volleth; Martin Zenker; Ivana Joksic; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2020-02-28       Impact factor: 2.479

5.  Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.

Authors:  Zhong Deng; Galina Glousker; Aliah Molczan; Alan J Fox; Noa Lamm; Jayaraju Dheekollu; Orr-El Weizman; Michael Schertzer; Zhuo Wang; Olga Vladimirova; Jonathan Schug; Memet Aker; Arturo Londoño-Vallejo; Klaus H Kaestner; Paul M Lieberman; Yehuda Tzfati
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 6.  Why do viruses cause cancer? Highlights of the first century of human tumour virology.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

7.  Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.

Authors:  Noa Lamm; Elly Ordan; Rotem Shponkin; Carmelit Richler; Memet Aker; Yehuda Tzfati
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

8.  Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.

Authors:  Jürgen Rac; Florian Haas; Andrina Schumacher; Jaap M Middeldorp; Henri-Jacques Delecluse; Roberto F Speck; Michele Bernasconi; David Nadal
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 9.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

10.  Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.

Authors:  S A Kamranvar; X Chen; M G Masucci
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.